Bioequivalence Study of Clarithromycin 250 mg/5 mL Powder for Oral Suspension Under Fasting Conditions

Mise à jour : Il y a 4 ans
Référence : NCT00775255

  • | Pays :
  • India
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To compare the single-dose oral bioavailability of clarithromycin 250-mg/5 mL powder for oral suspension of Ranbaxy Laboratories with that of Abbott Laboratories (Biaxin®) following administration of a 250 mg/5 mL dose in healthy, adult, human, male subjects under fasting conditions.


Critère d'inclusion

  • Healthy

Liens